Additions Will Enhance Firm's Depth in ANDA and other IP Litigation While Building Its Presence in the Western Wisconsin Rocket Docket
Merchant & Gould, an intellectual property law firm, today announced that it has added two senior trial attorneys and two other partners, all of whom bring significant generic pharmaceutical and other IP litigation experience with them. All four have joined the Merchant & Gould firm as partners, and come from Michael Best & Friedrich LLP. The new partners, Jeffrey S. Ward, Thomas P. Heneghan, Edward J. Pardon, and Wendy M. Ward, will be based in Merchant & Gould's new office in Madison, Wisconsin, scheduled to open in April or early May.
The addition of these partners enhances the firm's existing experience in representation of generic pharmaceutical companies seeking to bring products to market under the Hatch-Waxman Act. Merchant & Gould offers the generic pharmaceutical industry an unparalleled level of depth and proficiency in chemistry as well as extensive trial experience, all within the cost-effective and competitive rate structure of a Midwestern intellectual property law firm.
"The combination of the depth of experience these highly-respected litigators bring to the firm with the unmatched depth and pharmaceutical experience of the firm's existing ANDA practice will allow Merchant & Gould to deliver an unprecedented level of excellence and value to the generic pharmaceutical industry without having to deviate from our midwestern rate structure," said Randy King, Managing Director and CEO of Merchant & Gould. "We are very excited about this group joining the firm to further augment our current successes and strengths within the life sciences market."
"Our competitive advantage and value in patent litigation hinges on our capacity to quickly understand complex technologies, create cost-effective and focused case strategies, and translate the case into a simple and compelling story for judges and juries," stated Dan McDonald, chair of the litigation practice group at Merchant & Gould. "The marriage between this experienced new group and our existing team, including several lawyers who are also PhD chemists and many others with extensive technical and trial backgrounds, enhances these strengths in a district known for moving patent cases quickly."
Jeffrey S. Ward
Mr. Ward has, for more than 20 years now, focused his practice on the representation of generic pharmaceutical companies with an emphasis on patent litigation. Mr. Ward also has represented companies in the United States and throughout the world with respect to patent litigation, counseling, and opinion matters across a wide range of technologies. He received his J.D. from the University of Illinois College of Law and holds a B.S. in Chemical Engineering, with distinction, from the University of Illinois. Mr. Ward is admitted to practice in the United States Patent and Trademark Office, numerous Federal District Courts, the Court of Appeals for the Federal Circuit, and the United States Supreme Court.
Thomas P. Heneghan
Mr. Heneghan has extensive experience in Hatch-Waxman litigation and has defended and prosecuted all aspects of intellectual property litigation claims, including trials in numerous states and appellate practice before the Federal Circuit Court of Appeals. He holds a J.D. with honors from DePaul University College of Law and a B.S. from the University of Wisconsin, Oshkosh.
Edward J. Pardon, M.D.
Dr. Pardon has extensive experience within patent litigation, including pharmaceutical patents and other clinically-related patents and technologies. He practiced medicine for ten years and has experience conducting basic and clinical research. He received his M.D. from the University of Wisconsin Medical School, obtained his J.D. magna cum laude from the University of Wisconsin Law School and holds a B.S. magna cum laude from Carroll College.
Wendy M. Ward
Ms. Ward has focused her practice within the life sciences industry, both in securing intellectual property protection and in patent litigation. She has extensive experience in technologies pertaining to pharmaceuticals, virology, molecular biology and research tools, cancer therapeutics and immunology. She has a J.D., cum laude, from the University of Wisconsin Law School and a B.S., with distinction, from the University of Wisconsin, Madison. Ms. Ward is admitted to practice in the United States Patent and Trademark Office and several Federal District Courts.